Why some Cryptococcus fungi cause severe infections
The Genetic Basis of Virulence in Cryptococcus Neoformans
Scientists are comparing the genes of different Cryptococcus fungi to learn why some strains make people very sick and to help patients with cryptococcal infections.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11257323 on NIH RePORTER |
What this research studies
You should know that researchers will compare the DNA of many Cryptococcus samples to find genes linked to traits like capsule size, heat tolerance, and drug resistance. They will create mapping populations and use genetic mapping (QTL) along with experimental evolution to see how fungi change under stress or drug exposure. The team will also apply a chemical epistasis approach to understand how different genes interact to produce more or less harmful strains. All work is lab-based on fungal isolates to build knowledge that could guide future tests or treatments.
Who could benefit from this research
Good fit: People who have had cryptococcal infections or who are at high risk (for example, people with HIV or weakened immune systems) are most likely to benefit from the findings.
Not a fit: People with non-fungal illnesses or who are not at risk for cryptococcal infection are unlikely to see direct benefit from this basic-lab research.
Why it matters
Potential benefit: If successful, this work could reveal genetic targets or diagnostic markers that make cryptococcal infections easier to detect and treat.
How similar studies have performed: Previous research has found some individual Cryptococcus virulence genes, but combining population genomics, QTL mapping, experimental evolution, and chemical epistasis is a relatively new approach.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Magwene, Paul Mitaari — Duke University
- Study coordinator: Magwene, Paul Mitaari
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.